» Articles » PMID: 18156300

Diabetic Nephropathy: Mechanisms of Renal Disease Progression

Overview
Specialty Biology
Date 2007 Dec 25
PMID 18156300
Citations 248
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic nephropathy is characterized by excessive amassing of extracellular matrix (ECM) with thickening of glomerular and tubular basement membranes and increased amount of mesangial matrix, which ultimately progress to glomerulosclerosis and tubulo-interstitial fibrosis. In view of this outcome, it would mean that all the kidney cellular elements, i.e., glomerular endothelia, mesangial cells, podocytes, and tubular epithelia, are targets of hyperglycemic injury. Conceivably, high glucose activates various pathways via similar mechanisms in different cell types of the kidney except for minor exceptions that are related to the selective expression of a given molecule in a particular renal compartment. To begin with, there is an obligatory excessive channeling of glucose intermediaries into various metabolic pathways with generation of advanced glycation products (AGEs), activation of protein kinase C (PKC), increased expression of transforming growth factor-beta (TGF-beta), GTP-binding proteins, and generation of reactive oxygen species (ROS). The ROS seem to be the common denominator in various pathways and are central to the pathogenesis of hyperglycemic injury. In addition, there are marked alterations in intraglomerular hemodynamics, i.e., hyperfiltration, and this along with metabolic derangements adversely compounds the hyperglycemia-induced injury. Here, the information compiled under various subtitles of this article is derived from an enormous amount of data summarized in several excellent literature reviews, and thus their further reading is suggested to gain in-depth knowledge of each of the subject matter.

Citing Articles

The UBR5 protein facilitates mesangial cell hypertrophy and glycolysis induced by high glucose by increasing the phosphorylation levels of AKT.

Liao L, Xu Q, Xu J, Chen J, Liu W, Chen W Acta Diabetol. 2025; .

PMID: 39945887 DOI: 10.1007/s00592-025-02464-9.


Vascular endothelial cell injury: causes, molecular mechanisms, and treatments.

Xia T, Yu J, Du M, Chen X, Wang C, Li R MedComm (2020). 2025; 6(2):e70057.

PMID: 39931738 PMC: 11809559. DOI: 10.1002/mco2.70057.


Acute hyperglycemia induces podocyte apoptosis by monocyte TNF-α release, a process attenuated by vitamin D and GLP-1 receptor agonists.

Zhang R, Oh J, Wice B, Dusso A, Bernal-Mizrachi C J Steroid Biochem Mol Biol. 2025; 247:106676.

PMID: 39818342 PMC: 11859504. DOI: 10.1016/j.jsbmb.2025.106676.


High glucose couples DJ-1 with PTEN to activate PDGFRβ for renal proximal tubular cell injury.

Das F, Ghosh-Choudhury N, Kasinath B, Sharma K, Ghosh Choudhury G PLoS One. 2025; 20(1):e0311828.

PMID: 39761275 PMC: 11703087. DOI: 10.1371/journal.pone.0311828.


mTOR pathway: A key player in diabetic nephropathy progression and therapeutic targets.

Shi J, Liu X, Jiao Y, Tian J, An J, Zou G Genes Dis. 2024; 12(2):101260.

PMID: 39717716 PMC: 11665407. DOI: 10.1016/j.gendis.2024.101260.